Efraim H. Rosenberg

2.5k total citations
27 papers, 1.1k citations indexed

About

Efraim H. Rosenberg is a scholar working on Clinical Biochemistry, Cell Biology and Oncology. According to data from OpenAlex, Efraim H. Rosenberg has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Clinical Biochemistry, 9 papers in Cell Biology and 8 papers in Oncology. Recurrent topics in Efraim H. Rosenberg's work include Metabolism and Genetic Disorders (10 papers), Muscle metabolism and nutrition (9 papers) and Cancer Genomics and Diagnostics (5 papers). Efraim H. Rosenberg is often cited by papers focused on Metabolism and Genetic Disorders (10 papers), Muscle metabolism and nutrition (9 papers) and Cancer Genomics and Diagnostics (5 papers). Efraim H. Rosenberg collaborates with scholars based in Netherlands, United States and Portugal. Efraim H. Rosenberg's co-authors include Gajja S. Salomons, Cornelis Jakobs, Lígia S. Almeida, Jan H.M. Schellens, Jos H. Beijnen, Gabe S. Sonke, Erik van Werkhoven, Dick Pluim, Suzanne Leijen and Robin M.J.M. van Geel and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Neurology.

In The Last Decade

Efraim H. Rosenberg

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Efraim H. Rosenberg Netherlands 15 413 320 316 235 214 27 1.1k
V. Poulaki United States 17 735 1.8× 64 0.2× 121 0.4× 300 1.3× 60 0.3× 34 1.3k
Rosa Aledo Spain 20 507 1.2× 66 0.2× 79 0.3× 58 0.2× 130 0.6× 36 882
Karen Keough United States 10 364 0.9× 64 0.2× 169 0.5× 51 0.2× 52 0.2× 16 878
Shun-Ai Li Japan 14 643 1.6× 188 0.6× 99 0.3× 52 0.2× 59 0.3× 17 1.0k
Vedam L. Ramprasad India 18 534 1.3× 90 0.3× 111 0.4× 51 0.2× 42 0.2× 61 1.1k
Mahnaz Bonrouhi Germany 14 493 1.2× 105 0.3× 30 0.1× 114 0.5× 134 0.6× 21 947
Oleg A. Shchelochkov United States 24 746 1.8× 55 0.2× 460 1.5× 36 0.2× 172 0.8× 47 1.3k
Mohga El‐Abbadi United States 14 439 1.1× 55 0.2× 55 0.2× 69 0.3× 80 0.4× 15 1.1k
Paul McGuire United States 18 580 1.4× 63 0.2× 107 0.3× 79 0.3× 62 0.3× 27 1.6k
Souska Zandi Switzerland 23 440 1.1× 64 0.2× 63 0.2× 138 0.6× 105 0.5× 59 1.4k

Countries citing papers authored by Efraim H. Rosenberg

Since Specialization
Citations

This map shows the geographic impact of Efraim H. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efraim H. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efraim H. Rosenberg more than expected).

Fields of papers citing papers by Efraim H. Rosenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Efraim H. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efraim H. Rosenberg. The network helps show where Efraim H. Rosenberg may publish in the future.

Co-authorship network of co-authors of Efraim H. Rosenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Efraim H. Rosenberg. A scholar is included among the top collaborators of Efraim H. Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Efraim H. Rosenberg. Efraim H. Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Talens, Francien, Yannick P. Kok, Mengting Chen, et al.. (2024). RAD51 recruitment but not replication fork stability associates with PARP inhibitor response in ovarian cancer patient-derived xenograft models. NAR Cancer. 6(4). zcae044–zcae044. 1 indexed citations
2.
Snæbjörnsson, Pétur, Efraim H. Rosenberg, Nicole C.T. van Grieken, et al.. (2022). Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer. PLoS ONE. 17(7). e0270591–e0270591. 1 indexed citations
3.
Menko, Fred H., Kim Monkhorst, Frans B.L. Hogervorst, et al.. (2022). Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation. Critical Reviews in Oncology/Hematology. 176. 103642–103642. 6 indexed citations
4.
Langen, Adrianus J. de, Sayed M.S. Hashemi, Kim Monkhorst, et al.. (2018). Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses. Lung Cancer. 124. 130–134. 15 indexed citations
5.
Crijns, Marianne B., Evelien Dekker, Barbara A.J. Bastiaansen, et al.. (2018). A squamous cell carcinoma in a young woman with Lynch syndrome. Familial Cancer. 18(2). 193–196. 5 indexed citations
6.
Snæbjörnsson, Pétur, Efraim H. Rosenberg, Peggy N. Atmodimedjo, et al.. (2016). Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment. Gut. 67(3). 447–455. 27 indexed citations
7.
Meulendijks, Didier, L. Dewit, Paul H.M. Smits, et al.. (2015). HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53. British Journal of Cancer. 112(8). 1358–1366. 77 indexed citations
8.
Pop, Ana, et al.. (2012). Detection of variants in SLC6A8 and functional analysis of unclassified missense variants. Molecular Genetics and Metabolism. 105(4). 596–601. 26 indexed citations
9.
Rosenberg, Efraim H., Lígia S. Almeida, Tjitske Kleefstra, et al.. (2010). Characterization of novel SLC6A8 variants with the use of splice-site analysis tools and implementation of a newly developed LOVD database. European Journal of Human Genetics. 19(1). 56–63. 15 indexed citations
10.
Rosenberg, Efraim H., Eduard A. Struys, Keith Hyland, et al.. (2009). Mutation detection in DNA isolated from cerebrospinal fluid and urine: Clinical utility and pitfalls of multiple displacement amplification. Molecular Genetics and Metabolism. 97(4). 312–314. 1 indexed citations
11.
Gallagher, Renata C., Johan L.K. Van Hove, Gunter Scharer, et al.. (2009). Folinic acid–responsive seizures are identical to pyridoxine‐dependent epilepsy. Annals of Neurology. 65(5). 550–556. 117 indexed citations
12.
Kamp, Jiddeke M. van de, Efraim H. Rosenberg, Arjan P.M. de Brouwer, et al.. (2008). Detection of low-level somatic and germline mosaicism by denaturing high-performance liquid chromatography in a EURO-MRX family with SLC6A8 deficiency. Neurogenetics. 9(3). 183–190. 25 indexed citations
13.
Rosenberg, Efraim H., Silvy J.M. van Dooren, Cornelis Jakobs, et al.. (2007). Functional characterization of missense variants in the creatine transporter gene (SLC6A8): improved diagnostic application. Human Mutation. 28(9). 890–896. 49 indexed citations
14.
Almeida, Lígia S., et al.. (2007). A prevalent pathogenic GAMT mutation (c.59G>C) in Portugal. Molecular Genetics and Metabolism. 91(1). 1–6. 17 indexed citations
15.
Clark, Amy J., Efraim H. Rosenberg, Lígia S. Almeida, et al.. (2006). X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology. Human Genetics. 119(6). 604–610. 101 indexed citations
16.
Almeida, Lígia S., Efraim H. Rosenberg, Nanda M. Verhoeven, et al.. (2006). Overexpression of GAMT restores GAMT activity in primary GAMT-deficient fibroblasts. Molecular Genetics and Metabolism. 89(4). 392–394. 6 indexed citations
17.
Rosenberg, Efraim H., et al.. (2006). Overexpression of wild‐type creatine transporter (SLC6A8) restores creatine uptake in primary SLC6A8‐deficient fibroblasts. Journal of Inherited Metabolic Disease. 29(2-3). 345–346. 5 indexed citations
18.
Almeida, Lígia S., Efraim H. Rosenberg, Nanda M. Verhoeven, Cornelis Jakobs, & Gajja S. Salomons. (2006). Are cerebral creatine deficiency syndromes on the radar screen?. Future Neurology. 1(5). 637–649. 12 indexed citations
19.
Rosenberg, Efraim H., Lígia S. Almeida, Tjitske Kleefstra, et al.. (2004). High Prevalence of SLC6A8 Deficiency in X-Linked Mental Retardation. The American Journal of Human Genetics. 75(1). 97–105. 148 indexed citations
20.
Taschner, Peter E.M., Jeroen C. Jansen, Bora E. Baysal, et al.. (2001). Nearly all hereditary paragangliomas in The Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes and Cancer. 31(3). 274–281. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026